ContactCredit ReportFinancialsPeopleOwnershipLatest ActivityMutual CompaniesDocumentsRepayment History

Cambridge Nucleomics Ltd

Cambridge Nucleomics Ltd is an active company incorporated on 15 January 2021 with the registered office located in Cambridge, Cambridgeshire. Cambridge Nucleomics Ltd was registered 4 years ago.
Status
Active
Active since incorporation
Company No
13135667
Private limited company
Age
4 years
Incorporated 15 January 2021
Size
Micro
Turnover is under £1M
Balance sheet is under £500,000
Under 10 employees
Confirmation
Submitted
Dated 14 January 2025 (7 months ago)
Next confirmation dated 14 January 2026
Due by 28 January 2026 (4 months remaining)
Last change occurred 2 years 7 months ago
Accounts
Submitted
For period 1 Jul30 Jun 2024 (1 year)
Accounts type is Total Exemption Full
Next accounts for period 30 June 2025
Due by 31 March 2026 (6 months remaining)
Contact
Address
Meditrina Building
Babraham Research Campus
Cambridge
CB22 3AT
England
Address changed on 1 Aug 2025 (1 month ago)
Previous address was Ketton Suite King Centre, Main Road Barleythorpe Oakham Rutland LE15 7WD England
Telephone
Unreported
Email
Unreported
People
Officers
5
Shareholders
6
Controllers (PSC)
2
Director • Director • British • Lives in England • Born in Mar 1957
Director • Professor • German • Lives in England • Born in Mar 1975
Director • Chinese • Lives in Hong Kong • Born in Apr 1982
Director • Ceo • German • Lives in England • Born in Feb 1991
Dr. Ulrich Felix Keyser
PSC • German • Lives in England • Born in Mar 1975
Shareholders, PSCs & Group Structure
See who truly controls a company with full PSC, Shareholder, and Group Structure exploration
Mutual Companies
Hybrid Access Technologies Limited
John Mark Yeomans is a mutual person.
Active
Christ's Hospital
John Mark Yeomans is a mutual person.
Active
Violin Limited
John Mark Yeomans is a mutual person.
Active
Wazoku Limited
John Mark Yeomans is a mutual person.
Active
Onebillion Learners
John Mark Yeomans is a mutual person.
Active
Time To Spare Ltd
John Mark Yeomans is a mutual person.
Active
Join The Rabble Ltd
John Mark Yeomans is a mutual person.
Dissolved
Rovco Limited
John Mark Yeomans is a mutual person.
In Administration
Financials
Net Assets, Total Assets & Total Liabilities (2022–2024)
Period Ended
30 Jun 2024
For period 30 Jun30 Jun 2024
Traded for 12 months
Cash in Bank
£10.39K
Decreased by £31.19K (-75%)
Turnover
Unreported
Same as previous period
Employees
2
Same as previous period
Total Assets
£35.55K
Decreased by £19.08K (-35%)
Total Liabilities
-£142.85K
Increased by £10.29K (+8%)
Net Assets
-£107.31K
Decreased by £29.37K (+38%)
Debt Ratio (%)
402%
Increased by 159.19% (+66%)
Latest Activity
Registered Address Changed
1 Month Ago on 1 Aug 2025
Full Accounts Submitted
5 Months Ago on 25 Mar 2025
Dr Max Zhu Appointed
6 Months Ago on 6 Mar 2025
Mr John Mark Yeomans Appointed
6 Months Ago on 3 Mar 2025
Confirmation Submitted
7 Months Ago on 27 Jan 2025
Full Accounts Submitted
1 Year 2 Months Ago on 25 Jun 2024
Confirmation Submitted
1 Year 7 Months Ago on 26 Jan 2024
Confirmation Submitted
2 Years 7 Months Ago on 25 Jan 2023
Dr. Ulrich Felix Keyser (PSC) Details Changed
2 Years 10 Months Ago on 28 Oct 2022
Hendrik Runge (PSC) Appointed
2 Years 10 Months Ago on 28 Oct 2022
Get Credit Report
Discover Cambridge Nucleomics Ltd's Credit Score, how much credit you can offer them, and how likely they are to repay you
Documents
Registered office address changed from Ketton Suite King Centre, Main Road Barleythorpe Oakham Rutland LE15 7WD England to Meditrina Building Babraham Research Campus Cambridge CB22 3AT on 1 August 2025
Submitted on 1 Aug 2025
Total exemption full accounts made up to 30 June 2024
Submitted on 25 Mar 2025
Memorandum and Articles of Association
Submitted on 13 Mar 2025
Resolutions
Submitted on 13 Mar 2025
Statement of capital following an allotment of shares on 6 March 2025
Submitted on 13 Mar 2025
Statement of capital following an allotment of shares on 3 March 2025
Submitted on 12 Mar 2025
Particulars of variation of rights attached to shares
Submitted on 12 Mar 2025
Change of share class name or designation
Submitted on 12 Mar 2025
Statement of capital following an allotment of shares on 6 March 2025
Submitted on 12 Mar 2025
Appointment of Dr Max Zhu as a director on 6 March 2025
Submitted on 11 Mar 2025
Repayment History
Understand how businesses repay their debts and see how they're performing year‐on‐year